Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Epigenetic Control of Atherosclerosis Via Dna Methylation: A New Therapeutic Target? Publisher Pubmed



Gorabi AM1 ; Penson PE2 ; Banach M3, 4 ; Motallebnezhad M5, 6, 7 ; Jamialahmadi T9 ; Sahebkar A8, 10, 11
Authors
Show Affiliations
Authors Affiliations
  1. 1. Research Center for Advanced Technologies in Cardiovascular Medicine, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, United Kingdom
  3. 3. Department of Hypertension, WAM University Hospital in Lodz, Medical University of Lodz, Zeromskiego 113, Lodz, Poland
  4. 4. Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland
  5. 5. Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  6. 6. Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
  7. 7. Department of Immunology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
  8. 8. Halal Research Center of IRI, FDA, Tehran, Iran
  9. 9. Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  10. 10. Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
  11. 11. Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Source: Life Sciences Published:2020


Abstract

Atherosclerosis is a disease in which lipid-laden plaques are developed inside the vessel walls of arteries. The immune system is activated, resulting in inflammation and oxidative stress. Endothelial cells (ECs) are activated, arterial smooth muscle cells (SMCs) proliferate, macrophages are activated, and foam cells are developed, leading to dysfunctional ECs. Epigenetic regulatory mechanisms, including DNA methylation, histone modifications, and microRNAs are involved in the modulation of genes that play distinct roles in several aspects of cell biology and physiology, hence linking environmental stimuli to gene regulation. Recent research has investigated the involvement of DNA methylation in the etiopathogenesis of atherosclerosis, and several studies have documented the role of this mechanism in various aspects of the disease. Regulation of DNA methylation plays a critical role in the integrity of ECs, SMC proliferation and formation of atherosclerotic lesions. In this review, we seek to clarify the role of DNA methylation in the development of atherosclerosis through different mechanisms. © 2020 Elsevier Inc.
Other Related Docs
12. Covid-19 Is an Endothelial Disease: Implications of Nitric Oxide, Advances in Experimental Medicine and Biology (2021)
17. Methylation in Colorectal Cancer, Epigenetics Territory and Cancer (2015)
18. New Insights to the Mechanisms Underlying Atherosclerosis in Rheumatoid Arthritis, International Journal of Rheumatic Diseases (2017)
29. Fluorimetric Detection of Methylated Dna of Sept9 Promoter by Silver Nanoclusters at Intrastrand 6C-Loop, Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy (2021)
31. Micrornas As the Actors in the Atherosclerosis Scenario, Journal of Physiology and Biochemistry (2020)
33. Statins: Beneficial Effects in Treatment of Covid-19, Advances in Experimental Medicine and Biology (2023)